Discovering the Extraordinary in the Unexpected: Dr. Fritz Sieber Celebrates 40 Years of Scientific Curiosity at MCW
Fritz Sieber, PhD, professor of pediatrics and medicine (hematology, oncology and bone marrow transplantation) and of microbiology and immunology at MCW, the most rewarding discoveries of his career rarely arrived according to plan.
"What I have enjoyed most about my work were the opportunities to exploit unexpected discoveries," Dr. Sieber said. "The discoveries that led to my patent applications, clinical trials and grant awards almost never started out as bulleted items on the to-do list of a grant application. They were almost always the outgrowth of serendipitous observations."
That openness to the unexpected has defined 40 years of research at MCW, where Dr. Sieber has spent his career pursuing projects aimed at improving the understanding, diagnosis and treatment of human disease.
Dr. Sieber arrived in Milwaukee in 1985 as what he describes as a "team of one," working out of an annex of the old Children's Hospital. What kept him at MCW, he said, was the institution's collaborative culture: access to adequate lab space and the opportunity for productive interactions with colleagues who brought complementary expertise to the table.
That early, solitary chapter did not last. As MCW's research infrastructure grew, so did his own work. When his lab moved to the newly constructed MACC Fund Building on MCW's main campus, staffing quickly grew to eight full-time employees and one part-time employee, allowing his team to take on more ambitious, labor-intensive projects and branch into new areas of research. The hiring of an organic synthetic chemist helped make his lab one of the few photobiology labs with its own in-house supply line for photosensitizing compounds, a distinction made possible by the caliber of talent MCW was able to attract.
Much of Dr. Sieber's research has centered on the compound Merocyanine 540, first examining its mechanisms as an anti-cancer and antiviral agent, then developing improved second-generation versions of the dye. His work later expanded into using related compounds to inactivate malaria parasites in blood, and eventually into researching selenium-based compounds, both as potential anti-cancer agents and as a way to help mitigate the harmful side effects of radiation and chemotherapy.
Among his proudest accomplishments, Dr. Sieber points to a 1986 milestone: a worldwide first, in which a leukemia patient received a transplant of the patient's own bone marrow cells after they had been treated in his lab with the dye Merocyanine 540 and light, in an effort to eliminate contaminating tumor cells. The protocol was soon adopted by transplant programs at then Milwaukee Children's Hospital, Johns Hopkins Cancer Center and Temple University Cancer Center.
"The most rewarding results were obtained in patients with high-risk AML [acute myeloid leukemia], showing long-term disease-free survival of 50 percent," Dr. Sieber said.
He recalls the emotional weight of that work vividly. "Some of my favorite memories date back to the pioneering days of the phase I/II trial of Merocyanine 540 as a marrow purging agent," he said. "First, we felt great relief when the patients engrafted. Then, about 10 years later, we felt similarly relieved when we learned that some patients were still alive and had remained free of disease."
Dr. Sieber's contributions have been recognized throughout his career. In 1987, he received the Stohlman Memorial Scholar Award from The Leukemia Society of America. In 1991, a paper he co-authored was recognized as the "Most Cited Experimental Hematology Article" at the 20th Annual Meeting of the International Society for Experimental Hematology in Parma, Italy. Seven years later, two more of his papers were ranked among the top 2% of publications in the journal Experimental Hematology between 1990 and 1998. In 2004, he was invited to deliver the inaugural plenary lecture at the 9th International Conference on the Chemistry of Selenium and Tellurium in Bombay, India.
Please join us in congratulating Dr. Fritz Sieber on 40 remarkable years of service to MCW. His curiosity, persistence and willingness to follow unexpected discoveries wherever they led have advanced the understanding and treatment of disease far beyond MCW's campus. We are deeply grateful for his contributions and for the legacy of discovery he has built.